{"id":534778,"date":"2021-09-07T08:05:04","date_gmt":"2021-09-07T12:05:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\/"},"modified":"2021-09-07T08:05:04","modified_gmt":"2021-09-07T12:05:04","slug":"kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\/","title":{"rendered":"Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p>WATERTOWN, Mass., Sept.  07, 2021  (GLOBE NEWSWIRE) &#8212; Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that management will participate in the following virtual healthcare investor conferences in September 2021:<\/p>\n<p>\n        <strong>H.C. Wainwright 23<\/strong><br \/>\n        <sup><br \/>\n          <strong>rd<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Global Investment Conference<\/strong><br \/>\n        <br \/>A pre-recorded presentation will be made available beginning Monday, September 13, 2021 at 7:00 a.m. ET.<\/p>\n<p>\n        <strong>Cantor Global Healthcare Conference 2021<\/strong><br \/>\n        <br \/>A pre-recorded presentation will be made available beginning Tuesday, September 28, 2021 at 4:40 p.m. ET.<\/p>\n<p>Management will also be available for virtual 1&#215;1 meetings on the same day as each presentation.<\/p>\n<p>To access the webcasts and subsequent archived recording of each presentation, please visit \u201cEvents\u201d in the \u201cInvestors\u201d section of the Kala website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Y7-rVaQ_XVawQrh2IorgFhh3uJAEr-IPZ9gK7mYezBSX-DKp9tzMzQK5j8514L4DCNA8clHmx3Pt-3g229fPhw==\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/kalarx.com<\/a>. An archived replay of the presentations will be available on the Company\u2019s website for at least 30 days following each event.<\/p>\n<p align=\"justify\">\n        <strong>About Kala Pharmaceuticals, Inc.<\/strong>\n      <\/p>\n<p>Kala is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye. Kala has applied its AMPPLIFY\u00ae mucus-penetrating particle (MPP) Drug Delivery Technology to two ocular therapies, EYSUVIS\u00ae (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of signs and symptoms of dry eye disease and INVELTYS\u00ae (loteprednol etabonate ophthalmic suspension) 1% for the treatment of post-operative inflammation and pain following ocular surgery. The Company also has a pipeline of pre-clinical development programs targeted to address unmet medical needs, including both front and back of the eye diseases. For more information on Kala, please visit www.kalarx.com.<\/p>\n<p>\n        <strong>Investor Contacts: <\/strong><br \/>\n        <br \/>Jill Steier<br \/>jill.steier@kalarx.com<br \/>781-996-5252<\/p>\n<p>Hannah Deresiewicz<br \/>hannah.deresiewicz@sternir.com <br \/>212-362-1200<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA0NCM0Mzg1ODM5IzIwODkyODU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NWRkY2ZlMDUtNTI1NS00NzYyLTk0MzYtYzk5NjFmMzQwYTdmLTExMDA4NTY=\/tiny\/Kala-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WATERTOWN, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) &#8212; Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that management will participate in the following virtual healthcare investor conferences in September 2021: H.C. Wainwright 23 rd Annual Global Investment Conference A pre-recorded presentation will be made available beginning Monday, September 13, 2021 at 7:00 a.m. ET. Cantor Global Healthcare Conference 2021 A pre-recorded presentation will be made available beginning Tuesday, September 28, 2021 at 4:40 p.m. ET. Management will also be available for virtual 1&#215;1 meetings on the same day as each presentation. To access the webcasts and subsequent archived recording of each presentation, please &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-534778","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WATERTOWN, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) &#8212; Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that management will participate in the following virtual healthcare investor conferences in September 2021: H.C. Wainwright 23 rd Annual Global Investment Conference A pre-recorded presentation will be made available beginning Monday, September 13, 2021 at 7:00 a.m. ET. Cantor Global Healthcare Conference 2021 A pre-recorded presentation will be made available beginning Tuesday, September 28, 2021 at 4:40 p.m. ET. Management will also be available for virtual 1&#215;1 meetings on the same day as each presentation. To access the webcasts and subsequent archived recording of each presentation, please &hellip; Continue reading &quot;Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-07T12:05:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA0NCM0Mzg1ODM5IzIwODkyODU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September 2021\",\"datePublished\":\"2021-09-07T12:05:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\\\/\"},\"wordCount\":287,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTA0NCM0Mzg1ODM5IzIwODkyODU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\\\/\",\"name\":\"Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTA0NCM0Mzg1ODM5IzIwODkyODU=\",\"datePublished\":\"2021-09-07T12:05:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTA0NCM0Mzg1ODM5IzIwODkyODU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTA0NCM0Mzg1ODM5IzIwODkyODU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\/","og_locale":"en_US","og_type":"article","og_title":"Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September 2021 - Market Newsdesk","og_description":"WATERTOWN, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) &#8212; Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that management will participate in the following virtual healthcare investor conferences in September 2021: H.C. Wainwright 23 rd Annual Global Investment Conference A pre-recorded presentation will be made available beginning Monday, September 13, 2021 at 7:00 a.m. ET. Cantor Global Healthcare Conference 2021 A pre-recorded presentation will be made available beginning Tuesday, September 28, 2021 at 4:40 p.m. ET. Management will also be available for virtual 1&#215;1 meetings on the same day as each presentation. To access the webcasts and subsequent archived recording of each presentation, please &hellip; Continue reading \"Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-07T12:05:04+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA0NCM0Mzg1ODM5IzIwODkyODU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September 2021","datePublished":"2021-09-07T12:05:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\/"},"wordCount":287,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA0NCM0Mzg1ODM5IzIwODkyODU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\/","name":"Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA0NCM0Mzg1ODM5IzIwODkyODU=","datePublished":"2021-09-07T12:05:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA0NCM0Mzg1ODM5IzIwODkyODU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA0NCM0Mzg1ODM5IzIwODkyODU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kala-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-september-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/534778","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=534778"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/534778\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=534778"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=534778"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=534778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}